Evidence map›Paper›PMID 38005670›Full record

ArticleSensors (Basel, Switzerland)2023

Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder.

Luana Cecilia Farache Lemos Leal, Luiz Henrique Bertucci Borges, Maria Eduarda Franklin da Costa De Paula, Lilian Lira Lisboa, André Felipe Oliveira de Azevedo Dantas

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luana Cecilia Farache Lemos LealGraduate Program in Neuroengineering, Edmond and Lily Safra International Institute of Neuroscience, Macaíba 59280-000, RN, Brazil.ORCID 0000-0002-7527-9953
Luiz Henrique Bertucci BorgesGraduate Program in Neuroengineering, Edmond and Lily Safra International Institute of Neuroscience, Macaíba 59280-000, RN, Brazil.ORCID 0000-0001-6646-5140
Maria Eduarda Franklin da Costa De PaulaOrby, Co., Orby Systems Development LTDA, Natal 59000-000, RN, Brazil.ORCID 0000-0002-4589-7734
Lilian Lira LisboaGraduate Program in Neuroengineering, Edmond and Lily Safra International Institute of Neuroscience, Macaíba 59280-000, RN, Brazil.ORCID 0000-0003-0744-255X
André Felipe Oliveira de Azevedo DantasGraduate Program in Neuroengineering, Edmond and Lily Safra International Institute of Neuroscience, Macaíba 59280-000, RN, Brazil.ORCID 0000-0002-4172-3913

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurogenic bladder is a dysfunction in the lower urinary tract due to damage to the nervous system. One of the treatments that has shown important results is transcutaneous neuromodulation. The neuromodulation equipment available on the market does not allow remote activation or offer many resources for adjusting the parameters of the generated stimulus, as most devices operate with pre-established parameters in closed packages. For this reason, customizing therapy for each individual can be difficult. Therefore, the objective was to develop and validate a neuromodulation device capable of being remotely programmed and properly monitored. Materials and methods for validating devices were used according to the Brazilian Regulatory Standard (NBR), which deals with general requirements for the basic safety and essential performance of electromedical devices. After verifying the reliability of the device, which was capable of generating a biphasic and symmetrical wave, measured by an oscilloscope, considered safe by the technical requirements, it was tested in a real application. Users reported feeling a comfortable stimulus, similar to other previously used devices, and considered the device easy to use. In this way, it was possible to demonstrate the reliability and validity of the developed device.

Indexed as

Electric Stimulation TherapyUrinary Bladder, NeurogenicBrazilHumansReproducibility of ResultsUrinary Bladderneurogenic bladderneuromodulationsystem development

Identifiers

PMID38005670
PMCPMC10674258
OpenAlexW4388834429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.